Evolution of Resistant M414T Mutants among Hepatitis C Virus Replicon Cells Treated with Polymerase Inhibitor A-782759
about
HCV Drug Resistance Challenges in Japan: The Role of Pre-Existing Variants and Emerging Resistant Strains in Direct Acting Antiviral TherapyThe Hepatitis C Virus Replicon Presents a Higher Barrier to Resistance to Nucleoside Analogs than to Nonnucleoside Polymerase or Protease InhibitorsMolecular Mechanism of Hepatitis C Virus Replicon Variants with Reduced Susceptibility to a Benzofuran Inhibitor, HCV-796Selected Replicon Variants with Low-Level In Vitro Resistance to the Hepatitis C Virus NS5B Polymerase Inhibitor PSI-6130 Lack Cross-Resistance with R1479Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patientsGenetic heterogeneity of hepatitis C virus in association with antiviral therapy determined by ultra-deep sequencingA new stochastic model for subgenomic hepatitis C virus replication considers drug resistant mutantsIndian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016.Global prevalence of pre-existing HCV variants resistant to direct-acting antiviral agents (DAAs): mining the GenBank HCV genome dataUltradeep sequencing study of chronic hepatitis C virus genotype 1 infection in patients treated with daclatasvir, peginterferon, and ribavirin.Therapeutic implications of hepatitis C virus resistance to antiviral drugs.Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy.Preexisting drug-resistance mutations reveal unique barriers to resistance for distinct antiviralsInhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B.Compensatory mutations restore the replication defects caused by cytotoxic T lymphocyte escape mutations in hepatitis C virus polymerase.Resistance mechanisms in HCV: from evolution to intervention.Ultrasensitive genotypic detection of antiviral resistance in hepatitis B virus clinical isolates.Comparative study of the genetic barriers and pathways towards resistance of selective inhibitors of hepatitis C virus replication.Allele-specific real-time PCR system for detection of subpopulations of genotype 1a and 1b hepatitis C NS5B Y448H mutant viruses in clinical samples.Genotypic and phenotypic analyses of hepatitis C virus from patients treated with JTK-853 in a three-day monotherapy.Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1.Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3.4A protease inhibitors in treatment-naive subjects.Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivo.
P2860
Q26782405-C0692E05-3D04-474F-82FC-06193BA15D24Q27485895-FBED6930-4EC0-4A6D-8CD8-926498003AF2Q27486816-E8E92370-7300-4969-A647-619B0D9AA003Q27487389-F66459F7-D831-49C9-B137-E7B42A8FC601Q27487949-5DA37CE6-5E1F-4FE0-8C30-6F3490A05620Q28477175-5F5AE5D5-D18E-4569-9E97-760D9F9E9307Q28541048-5C934F11-2BF4-4759-86DC-828CF6CF31CFQ30355190-191E83DC-668D-44EA-9532-88D5E9676178Q31042796-CB5DCD8D-A8A8-43F5-AD57-4938D162DC3CQ33622970-46CB80DB-90A6-4415-BCB5-61C41E4DEECFQ34409020-25CD3216-6E4E-49E4-98DE-2A98C25946F5Q34957256-CEFD2C00-46C6-48F8-B646-440E1776763BQ35064369-13206A5E-901A-4302-897D-6161E9242530Q35260330-AA4B0580-05C2-4803-B476-DE9C4CA4238BQ35531173-49E6DEB1-3F42-410A-BF86-80D34615C5DCQ37228736-A021AC66-735B-435B-9089-B629874A1A68Q37247742-6F3CFB69-CD52-41B6-907E-2B3402D880B8Q38283239-7B1F62FC-AC11-4487-A7ED-D01638C9C406Q38284922-13BAA274-8F70-47D7-84A3-9EA22EF9619CQ42075048-E96B1F8A-5C20-4DBB-B658-C7D069DFAA5CQ42211518-A501DA99-DB4E-4172-A94A-C00C893ADD84Q42980129-997DE504-471B-4C28-940E-55A9214BFE35Q43037298-194AD24D-C01B-49F7-A8D0-EE9339ABF1D2
P2860
Evolution of Resistant M414T Mutants among Hepatitis C Virus Replicon Cells Treated with Polymerase Inhibitor A-782759
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Evolution of Resistant M414T M ...... Polymerase Inhibitor A-782759
@ast
Evolution of Resistant M414T M ...... Polymerase Inhibitor A-782759
@en
Evolution of Resistant M414T M ...... Polymerase Inhibitor A-782759
@nl
type
label
Evolution of Resistant M414T M ...... Polymerase Inhibitor A-782759
@ast
Evolution of Resistant M414T M ...... Polymerase Inhibitor A-782759
@en
Evolution of Resistant M414T M ...... Polymerase Inhibitor A-782759
@nl
prefLabel
Evolution of Resistant M414T M ...... Polymerase Inhibitor A-782759
@ast
Evolution of Resistant M414T M ...... Polymerase Inhibitor A-782759
@en
Evolution of Resistant M414T M ...... Polymerase Inhibitor A-782759
@nl
P2093
P2860
P356
P1476
Evolution of Resistant M414T M ...... Polymerase Inhibitor A-782759
@en
P2093
Akhteruzzaman Molla
Hongmei Mo
Liangjun Lu
Tami J Pilot-Matias
P2860
P304
P356
10.1128/AAC.01004-06
P407
P577
2007-06-01T00:00:00Z